Somatic Reversion of Germline <i>BRCA2</i> Mutation Confers Resistance to Poly(ADP-ribose) Polymerase Inhibitor Therapy.

Somatic Reversion of Germline BRCA2 Mutation Confers Resistance to Poly(ADP-ribose) Polymerase Inhibitor Therapy.

Banda, Kalyan; Swisher, Elizabeth M; Wu, David; Pritchard, Colin C; Gadi, V K.

Afiliación

Banda K; All authors, University of Washington; Kalyan Banda and V.K. Gadi, Fred Hutchinson Cancer Research Center; and Elizabeth M. Swisher and V.K. Gadi, Seattle Cancer Care Alliance, Seattle, WA.
Swisher EM; All authors, University of Washington; Kalyan Banda and V.K. Gadi, Fred Hutchinson Cancer Research Center; and Elizabeth M. Swisher and V.K. Gadi, Seattle Cancer Care Alliance, Seattle, WA.
Wu D; All authors, University of Washington; Kalyan Banda and V.K. Gadi, Fred Hutchinson Cancer Research Center; and Elizabeth M. Swisher and V.K. Gadi, Seattle Cancer Care Alliance, Seattle, WA.
Pritchard CC; All authors, University of Washington; Kalyan Banda and V.K. Gadi, Fred Hutchinson Cancer Research Center; and Elizabeth M. Swisher and V.K. Gadi, Seattle Cancer Care Alliance, Seattle, WA.
Gadi VK; All authors, University of Washington; Kalyan Banda and V.K. Gadi, Fred Hutchinson Cancer Research Center; and Elizabeth M. Swisher and V.K. Gadi, Seattle Cancer Care Alliance, Seattle, WA.

JCO Precis Oncol ; 2: 1-6, 2018 Nov.

Article en En | MEDLINE | ID: mdl-35135104

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: JCO Precis Oncol Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: JCO Precis Oncol Año: 2018 Tipo del documento: Article